Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Abroad (travel likely)RecruitingPHASE3

Conditions

Gastric Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of General, Oncological, Gastroenterological Surgery and Transplantology, Krakow, Lesser Poland Voivodship, Poland
Contact: Study coordinator (Piotr Richter, Professor) · piotr.richter@uj.edu.pl · +48124002400

Study leads

Piotr Richter, Professor
Study Director
Jagiellonian University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer

Gastric Cancer, Gastroesophageal Junction Cancer

Abroad (travel likely)Recruiting

Chongqing, China · Chongqing, China

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

Gastric Cancer · Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China · Xiamen, China

Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China · Guiyang, China

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma (Skin)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Grand Rapids, United States · St Louis, United States